BDMD Statistics
Total Valuation
BDMD has a market cap or net worth of $55.14 million. The enterprise value is $74.11 million.
Important Dates
The last earnings date was Wednesday, April 29, 2026, before market open.
| Earnings Date | Apr 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BDMD has 30.81 million shares outstanding. The number of shares has increased by 27.33% in one year.
| Current Share Class | 30.81M |
| Shares Outstanding | 30.81M |
| Shares Change (YoY) | +27.33% |
| Shares Change (QoQ) | +10.53% |
| Owned by Insiders (%) | 59.69% |
| Owned by Institutions (%) | 1.95% |
| Float | 4.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.45 |
| Forward PS | n/a |
| PB Ratio | 1.17 |
| P/TBV Ratio | 1.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.70, with a Debt / Equity ratio of 0.62.
| Current Ratio | 1.70 |
| Quick Ratio | 1.33 |
| Debt / Equity | 0.62 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -34.75 |
Financial Efficiency
Return on equity (ROE) is -77.60% and return on invested capital (ROIC) is -51.06%.
| Return on Equity (ROE) | -77.60% |
| Return on Assets (ROA) | -21.70% |
| Return on Invested Capital (ROIC) | -51.06% |
| Return on Capital Employed (ROCE) | -68.65% |
| Weighted Average Cost of Capital (WACC) | -0.77% |
| Revenue Per Employee | $157,602 |
| Profits Per Employee | -$190,755 |
| Employee Count | 143 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 3.07 |
Taxes
In the past 12 months, BDMD has paid $1.17 million in taxes.
| Income Tax | 1.17M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.87% in the last 52 weeks. The beta is -1.15, so BDMD's price volatility has been lower than the market average.
| Beta (5Y) | -1.15 |
| 52-Week Price Change | -68.87% |
| 50-Day Moving Average | 2.08 |
| 200-Day Moving Average | 1.80 |
| Relative Strength Index (RSI) | 48.22 |
| Average Volume (20 Days) | 227,946 |
Short Selling Information
The latest short interest is 331,842, so 1.08% of the outstanding shares have been sold short.
| Short Interest | 331,842 |
| Short Previous Month | 621,861 |
| Short % of Shares Out | 1.08% |
| Short % of Float | 7.11% |
| Short Ratio (days to cover) | 0.52 |
Income Statement
In the last 12 months, BDMD had revenue of $22.54 million and -$27.28 million in losses. Loss per share was -$0.98.
| Revenue | 22.54M |
| Gross Profit | 18.88M |
| Operating Income | -25.63M |
| Pretax Income | -26.37M |
| Net Income | -27.28M |
| EBITDA | -24.53M |
| EBIT | -25.63M |
| Loss Per Share | -$0.98 |
Full Income StatementBalance Sheet
The company has $418,868 in cash and $19.39 million in debt, with a net cash position of -$18.97 million or -$0.62 per share.
| Cash & Cash Equivalents | 418,868 |
| Total Debt | 19.39M |
| Net Cash | -18.97M |
| Net Cash Per Share | -$0.62 |
| Equity (Book Value) | 31.22M |
| Book Value Per Share | 1.52 |
| Working Capital | 22.61M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$1.34 million and capital expenditures -$42,315, giving a free cash flow of -$1.39 million.
| Operating Cash Flow | -1.34M |
| Capital Expenditures | -42,315 |
| Depreciation & Amortization | 1.10M |
| Net Borrowing | -1.39M |
| Free Cash Flow | -1.39M |
| FCF Per Share | -$0.05 |
Full Cash Flow StatementMargins
Gross margin is 83.79%, with operating and profit margins of -113.73% and -121.04%.
| Gross Margin | 83.79% |
| Operating Margin | -113.73% |
| Pretax Margin | -117.03% |
| Profit Margin | -121.04% |
| EBITDA Margin | -108.83% |
| EBIT Margin | -113.73% |
| FCF Margin | n/a |
Dividends & Yields
BDMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -27.33% |
| Shareholder Yield | -27.33% |
| Earnings Yield | -49.47% |
| FCF Yield | -2.51% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BDMD has an Altman Z-Score of 1.47 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.47 |
| Piotroski F-Score | 1 |
